7 April, 2005 | ||
![]() |
||
|
||
![]() |
||
![]() |
Olympus Corporation (Olympus, President: Tsuyoshi Kikukawa) has formed a technology partnership with AntiCancer Inc. (CEO: Dr. Robert M. Hoffman, headquarters: San Diego, California, U.S.A.). Starting in April 2005, the two companies will conduct joint research, applying AntiCancer's proprietary fluorescent-protein-based small-animal imaging technology to a highly sensitive fluorescence molecular imaging system developed by Olympus. |
![]() |
Olympus will display its in vivo molecular imaging system and micro laser scanning microscope in its booth at the annual meeting of the American Association for Cancer Research (President. Lynn M. Matrisian, Ph.D.), to be held in Anaheim, California, April 16-20, 2005. |
![]() |
Background |
![]() |
![]() |
![]() |
![]() |
![]() |
Overview of AntiCancer Inc. |
![]() |
|
||||||||||||
![]() |
![]() |
- Press releases are company announcements that are directed at the news media.
- Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.
- Company names and product names specified are trademarks of their respective owners.